
H1 secures $40M from CVS, proving SaaS startups can still attract investment - TechCrunch
H1 is a healthcare data platform that provides detailed information about doctors to pharmaceutical companies, hospital systems, and health insurers. The company has recently secured a $40 million investment from CVS Health Ventures, highlighting its strong financial fundamentals and growth potential in a challenging investment environment.
H1 secures $40M from CVS, proving SaaS startups can still attract investment TechCrunch

| Jun 18, 2026 | Interchecks | $50.0M | Series C | United States |
| Jun 18, 2026 | American Perpetuals Exchange Corporation | $30.0M | — | United States |
| Jun 18, 2026 | Miami fintech | $140.0M | — | United States |
| Jun 18, 2026 | General Intuition | $300.0M | — | United States |